Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 23, 2019 (7 years ago)

Prednisolone Sodium Phosphate Oral Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx only, Manufactured By Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053. NDC 60432-212-08

Affected NDC 60432-0212-08

Compare with the code on your package — it is the most precise check available.

Drug: Prednisolone

Recalling firm
Morton Grove Pharmaceuticals, Inc.
NDC code
60432-212-08
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0130-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Prednisolone recalls

See all

Other recalls by Morton Grove Pharmaceuticals, Inc.

All 2019 recalls
Class II · Moderate risk

Dexamethasone Elixir

Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.

Terminated Impurity / degradation Morton Grove Pharmaceuticals, Inc. NDC 60432-466-08 D-0713-2022
Class II · Moderate risk

Valproic Acid Oral Solution USP

CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Completed Microbial contamination Morton Grove Pharmaceuticals, Inc. D-0816-2021
Class II · Moderate risk

Promethazine Syrup Plain

CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Completed Microbial contamination Morton Grove Pharmaceuticals, Inc. D-0814-2021